Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomesHeather J. Bax, Debra H. Josephs, Gabriel Osborn et al.|British Journal of Cancer|2022Cited by 89
Abstract CT141: Phase 1 trial of MOv18, a first-in-class IgE antibody therapy for cancerJames Spicer, Sophia N. Karagiannis, Bristi Basu et al.|Cancer Research|2020Cited by 18